LakePharma and NJ Bio partner on ‘one-stop’ ADC manufacturing service

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/extender01)
(Image: Getty/extender01)

Related tags: Antibody drug conjugates, antibody-drug conjugates, Antibody, Contract manufacturing

Antibody-focused service providers merge their offerings to create a ‘seamless workflow’ on antibody-drug conjugates to help save developers’ time and costs.

LakePharma, a US-based biologics contract research, development, and manufacturing organization (CRDMO), will work jointly with NJ Biopharmaceuticals, a provider of chemistry and biology services, to create a streamlined antibody-drug conjugate (ADC) development service.

Specifically, the agreement will see LakePharma manufacture and provide antibodies as starting materials for ADC development, which will be carried out by NJ Bio, in order to support drug developers working on such treatments.

This joint service, leveraging the capabilities of both companies in their field, is expected to create a ‘seamless workflow’ for clients, from initial antibody discovery to the production of the drug conjugates in a manner “significantly more efficient both in time and expense,”​ LakePharma stated.

Commenting on the partnership, Nareshkumar Jain, CEO of NJ Bio, stated that the partnership will expand and add value to the ADC services that the companies currently provide, creating cost-effective solutions through the provision of complementary service offerings.

The therapeutic potential of ADCs and their uptake from the industry has seen several companies establishing partnerships, such as AstraZeneca with Daiichi Sankyo​ last year, as well as investment in capabilities, such as that of Lonza​ – which stated that it was preparing for a ‘new wave’ of ADC therapies.

Related news

Show more

Related products

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Partner with Experts in Precision Medicine

Partner with Experts in Precision Medicine

CellCarta | 17-Jan-2022 | Product Brochure

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Related suppliers